ZhuoerXieMD

PubMed

• When to use which molecular prognostic scoring system in the management of patients with MDS?
  Gurnari, C., Kewan, T., Bewersdorf, J., Xie, Z., Zeidan, A., Stahl, M.> ;Best Practice & Research. Clinical Haematology. 2023 Dec 1
• Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities.
  Nathan P Horvat, Enas F Abdallah, Zhuoer Xie, Najla Al Ali, Seongseok Yun, Alison Walker, Eric Padron, David Sallman, Onyee Chan, Jeffrey Lancet, Rami Komrokji, Andrew...> ;Annals of Hematology. 2024 Jan 1
• 1 citations
  Development of an Automated, High-Throughput Methodology for Native Mass Spectrometry and Collision-Induced Unfolding.
  Brock R Juliano, Joseph W Keating, Henry W Li, Anna G Anders, Zhuoer Xie, Brandon T Ruotolo> ;Analytical Chemistry. 2023 Nov 14
• 6 citations
  Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Cons...
  Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami Komrokji, Mina L Xu, Omar Abdel-Wahab, Justin Taylor, David P Steensma, Daniel ...> ;Blood Reviews. 2023 Nov 1
• 1 citations
  Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution.
  Enrico Santinelli, Maria Rosaria Pascale, Zhuoer Xie, Talha Badar, Maximilian F Stahl, Jan P Bewersdorf, Carmelo Gurnari, Amer M Zeidan> ;Blood Reviews. 2023 Nov 1
• 22 citations
  Spectrum of clonal hematopoiesis in VEXAS syndrome.
  Ombrello, A. K., Ombrello, A. K., Fernanda Gutierrez-Rodrigues, Yael Kusne, Jenna Fernandez, Terra Lasho, Ruba Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy Finke, Matth...> ;Blood. 2023 Jul 20
• 1 citations
  Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML).
  Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, Christy Finke, Aref Al-Kali, Naseema Gangat, Mithun V Shah, Hassan B Alkhateeb, Ayalew Tefferi, David Sallman, Zhuoer ...> ;Leukemia. 2023 Aug 1
• 1 citations
  Evolution of Therapeutic Benefit Measurement Criteria in Myelodysplastic Syndromes/Neoplasms.
  Jessica M Stempel, Zhuoer Xie, Jan Philipp Bewersdorf, Amer M Zeidan, Maximilian Stahl> ;Cancer Journal. 2023 May 17
• 2 citations
  Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes.
  Rami S Komrokji, Luis E Aguirre, Najla H Al Ali, Onyee Chan, Zhuoer Xie, Andrew Kuykendall, Kendra Sweet, Jeffrey E Lancet, Eric Padron, David A Sallman> ;Blood Advances. 2023 Jul 25
• 2 citations
  What's Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach.
  Hussein Awada, Carmelo Gurnari, Zhuoer Xie, Jan Philipp Bewersdorf, Amer M Zeidan> ;Cancers. 2023 Apr 12
• 2 citations
  Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis.
  Terra Lasho, Christy Finke, Michael Timm, Ayalew Tefferi, Abhishek Mangaonkar, Horatiu Olteanu, Kaaren Reichard, Rhett Ketterling, Naseema Gangat, Zhuoer Xie, Jenna Fe...> ;Leukemia. 2023 Jun 1
• 3 citations
  Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease.
  Nadia Akhiyat, Terra Lasho, Morsaleh Ganji, Takumi Toya, Chang-Xin Shi, Xianfeng Chen, Esteban Braggio, Ali Ahmad, Michel T Corban, Keith Stewart, Jenna Fernandez, Zhu...> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2023 May 1
• 7 citations
  Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1International Workshop on MDS (iwMDS) Of t...
  Jan Philipp Bewersdorf, Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M Brunner, Rena Buckstein, Hetty E Carraway, Jane E Churpek, Naval G Daver, ...> ;Blood Reviews. 2023 Jul 1
• 1 citations
  An overview of novel therapies in advanced clinical testing for acute myeloid leukemia.
  Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan> ;Expert Review of Hematology. 2023 Feb 1
• 3 citations
  Advances in myelodysplastic syndromes: promising novel agents and combination strategies.
  Yazan F Madanat, Zhuoer Xie, Amer M Zeidan> ;Expert Review of Hematology. 2023 Jan 1
• 20 citations
  Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
  Vikas, P., Portuguese, A. J., Ziad Bakouny, Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih-Yuan Hsu, Saif I Alimohamed, Babar Bashir, Stephanie Berg, Me...> ;JAMA Oncology. 2023 Jan 1
• 2 citations
  How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms.
  Carmelo Gurnari, Zhuoer Xie, Amer M Zeidan> ;Clinical Hematology International. 2023 Mar 1
• 1 citations
  Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms.
  Mrinal M Patnaik, Amer M Zeidan, Eric Padron, Uwe Platzbecker, David A Sallman, Amy E DeZern, Rafael Bejar, Mikkael Sekeres, Justin Taylor, Richard F Little, Jan P Bew...> ;Leukemia. 2022 Dec 1
• 6 citations
  Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age.
  Zhuoer Xie, Evan C Chen, Maximilian Stahl, Amer M Zeidan> ;Blood Reviews. 2023 May 1
• 13 citations
  Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes.
  Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M ...> ;Leukemia. 2022 Dec 1
• 4 citations
  An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS.
  Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F Sanz, David A Sallman, Vale...> ;Blood Advances. 2023 Jun 27
• 5 citations
  CHIPing away the progression potential of CHIP: A new reality in the making.
  Zhuoer Xie, Amer M Zeidan> ;Blood Reviews. 2023 Mar 1
• 2 citations
  Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.
  Dragan Jevremovic, Ahmad Nanaa, Susan M Geyer, Michael Timm, Haya Azouz, Cynthia Hengel, Alexander Reberg, Rong He, David Viswanatha, Mohamad E Salama, Min Shi, Horati...> ;American Journal of Clinical Pathology. 2022 Oct 6
• 1 citations
  Physical Activity Behavior of Patients at a Skilled Nursing Facility: Longitudinal Cohort Study.
  Ramin Ramezani, Wenhao Zhang, Pamela Roberts, John Shen, David Elashoff, Zhuoer Xie, Annette Stanton, Michelle Eslami, Neil S Wenger, Jacqueline Trent, Antonia Petruse...> ;JMIR Mhealth and Uhealth. 2022 May 23
• 7 citations
  Clonal compositions involving epigenetic regulator and splicing mutations in CHIP, CCUS, MDS, and CMML.
  Zhuoer Xie, Gina Campestri, Terra Lasho, Christy Finke, Marissa Li, Moritz Binder, Jenna Fernandez, Horatiu Olteanu, Kaaren K Reichard, Rhett Ketterling, Mark Litzow, ...> ;Leukemia Research. 2022 May 1
• Join now to see all